Hard For Indian Drugmakers To Pass On Tariff Impact On US Consumers: Quadria Capital's Amit Verma
Indian pharmaceutical companies will find it harder to pass on the tariff cost to US consumers should the Donald Trump administration impose them, according to Amit Varma, managing partner at Quadria Capital.
"We are supplying life-threatening drugs to US consumers. If supply chains start getting affected, there will be hue and cry to make sure we circumvent this. If tariffs are in double-digit, there will be hit on balance sheets of Indian companies," Verma told NDTV Profit.
He also pointed out that it is "hard to pull off a complete shift" in manufacturing and entire supply chain to the US. This can only happen in long term, as its difficult to replicate the cost and price efficiency that India has developed, he added.
Varma also noted that in the contract development and manufacturing organisation or CDMO space, contracts are signed for long term supply and hence difficult to change. Therefore, given India's cost efficiency, even if there are marginal dip in operating margins, US clients will not turn away, he said.
Varma also said the diagnostic industry will become more organised as after Covid-19 pandemic, people have realised the importance of early diagnosis and treatment closer to where they live.
"There is huge growth expected in diagnostic sector. There is also scope in preventive and wellness medicine," he said.
Morover, Verma sees further consolidation in the hospital segment as the organised sector is just 10% of the total market. "The industry has matured and regulators will adapt."
As a healthcare-focussed private equity firm, Quadria Capital manages $3.5 billion in assets with exposure in fastest-growing economies in South Asia and Southeast Asia. Its portfolio includes Akums Drugs and Pharma Ltd., Maxvision Eye Hospitals and digital health company MediBuddy.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.